课题基金 / 基金详情

The mechanism of the enhanced sensitivityof anticancer drug andradioactive ray by the cox-2 inhibitor in oral squamous cell carcinoma

The mechanism of the enhanced sensitivityof anticancer drug andradioactive ray by the cox-2 inhibitor in oral squamous cell carcinoma
COX-2抑制剂增强口腔鳞癌抗癌药物及放射线敏感性的机制
批准号:
20791489
负责人:
TANIGUCHI Takahiro
金额:
$2.5万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2009

项目摘要

项目成果

TANIGUCHI Takahiro的其他基金

相似基金

相关文献

中文摘要
翻译
一方面,人们注意到环氧合酶(COX)在炎症组织中的表达,另一方面,近年来的研究表明COX在肿瘤的发生中起着重要的作用,COX-2在一些恶性肿瘤中被诱导高表达。在本研究中,COX-2选择性抑制剂倾向于增强抗癌药物和放射治疗对人口腔鳞癌细胞系的作用。这些结果表明,COX-2选择性抑制剂可能有助于提高口腔癌的治疗效果。
英文摘要
It's noted that expression of cyclooxygenase(COX) is induced in the inflammatory tissue, on the other hand, it is suggested that COX plays a significant role in oncogenesis during recent years, and high expression of COX-2 is induced in a number of the malignant neoplasm. In this study, the COX-2 selective inhibitor had tended to enhance the effect of anticancer drug and radiation against the human oral squamous carcinoma cell line. These results indicate that the COX-2 selective inhibitor may contribute to improving effect of oral cancer therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene therapy to prevent vascular remodeling-vascular smooth muscle cell as a target cell
  • 批准号:
    14570663
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.18万
  • 财政年份:
    2002
  • 负责人:
    TANIGUCHI Takahiro
  • 依托单位:
Identification of Adventitial cells and Molecular Mechanisms of Phenotypic Modulation in the vasclar remodeling after bolloon injury
  • 批准号:
    11670678
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.98万
  • 财政年份:
    1999
  • 负责人:
    TANIGUCHI Takahiro
  • 依托单位:
Vascular Smooth Muscle Cell Singnal Transduction in Vascular Remodeling
  • 批准号:
    09670719
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $1.73万
  • 财政年份:
    1997
  • 负责人:
    TANIGUCHI Takahiro
  • 依托单位:
海外基金